Purchase Order 75F40119P10693

Award Date 9/26/19
Potential Completion Date 12/31/22
Potential Value $130K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02451, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $111,539.32 firm-fixed-price purchase order to EHT Technologies GMBH, a for-profit limited liability company manufacturer, for a Test System of Engineered Heart Tissues (EHT). This system will be used by the FDA's Division of Applied Regulatory Science to study variations in heart cell contractility resulting from exposure to certain drugs or drug combinations in a more mature setting. The contract...
This is a firm-fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Ansys Inc., a provider of engineering simulation software and services. The contract, valued at $121,691.93, is for the provision of computational fluid dynamics (CFD) modeling software and does not have a set-aside designation. The contract was issued under Ansys' General Services Administration (GSA) Federal Supply Schedule IT-70 contract, a $558 million IDIQ vehicle that enables federal agencies...
The Department of Health and Human Services Food and Drug Administration awarded a $20,912 purchase order to Lavision, Inc. of Ypsilanti, Michigan to purchase a digital volume correlation software program. The one-year contract starting September 8, 2023 supports the FDA's need for 3D image processing software to analyze medical device testing data as part of its regulatory and product safety responsibilities. Lavision will deliver its DVC software program to the FDA for use through September...
This $164,555.50 firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian government agency, to Emulate Inc., a small business contractor, for the procurement of two Zoe Culture Modules and two Orb Hub Modules of the Human Emulation System. The award, made under a small business set-aside, supports the FDA's regulatory science initiatives and efforts to advance non-animal testing approaches. Emulate Inc. has a long history of providing...
This definitive, firm fixed-price contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to CFD Research Corporation, a for-profit organization, to develop a multiscale computational framework for assessing the bioequivalence of orally inhaled drugs. The $499,761 contract does not have a set-aside designation. The original solicitation was a Broad Agency Announcement (BAA) seeking research and development to advance FDA's mission of protecting...
The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Emulate Inc., a for-profit small business. The contract, valued at $145,260.00, is for the delivery of Emulate's CHIP-S1 Stretchable Chip, a product in their organ-on-a-chip technology line. This technology supports various FDA and HHS initiatives in areas such as personalized medicine, biosurveillance, infectious disease...
This federal contract award, valued at $496,171, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract is for expanding patient-generated health data training, which supports the FDA's Center for Devices and Radiological Health's (CDRH) need to enhance its capabilities in this area. The contract is structured as a Definitive Firm Fixed Price arrangement and does not have a set-aside...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $35,751.68 firm-fixed-price purchase order to Team Results USA LLC. This purchase order is for a one-year masterclass team simulation to be delivered in Silver Spring, Maryland from September 2023 through September 2024. As the regulatory agency responsible for protecting public health through ensuring the safety and effectiveness of human and veterinary drugs, medical devices, and other products, this...
This firm-fixed-price delivery order was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to Core Human Factors, Inc., a for-profit S-corporation. The $404,063 contract is to conduct a comparative use human factors study that evaluates whether certain user interface differences between pen-injector combination products affect user error rates among diabetic patients. This study is part of a larger $10,000,000 Indefinite...

The Department of Health and Human Services Food and Drug Administration awarded a $130,000 firm-fixed price purchase order to Dassault Systemes Americas Corp. to fulfill requirements for the agency's Critical Path computational whole heart modeling project. As requested in the original solicitation, Dassault Systemes will provide a one-year service agreement with an option for an additional year to perform whole human heart computations with a virtually implanted generic medical device using high-performance cloud computing. Online access to the resulting data, simulations and database will be provided to registered users, along with web-based capabilities for viewing data and simulations. No set-aside designation was applied to this award made under simplified acquisition procedures to support the FDA's efforts to advance medical device evaluation through computational modeling.

Generated 2/29/24, 9:44 AM